Breaking News Instant updates and real-time market news.

LSCC

Lattice Semiconductor

$5.46

-0.24 (-4.21%)

, DIS

Disney

$98.52

0.62 (0.63%)

09:46
09/16/17
09/16
09:46
09/16/17
09:46

Week in review: How Trump's policies moved stocks

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Trump and his administration with this weekly recap compiled by The Fly: 1. LATTICE: On Wednesday, President Trump issued an order prohibiting the acquisition of Lattice Semiconductor (LSCC) by, among others, China Venture Capital Fund, a Chinese corporation owned by Chinese state-owned entities. The President made the decision citing the potential that the foreign interest exercising control "might take action that threatens to impair the national security of the U.S." The news also weighed on MoneyGram (MGI), which has agreed to be acquired by Ant Financial, the financial-services company controlled by Alibaba's (BABA) Jack Ma. 2. ESPN: On Friday, President Trump tweeted about Disney's (DIS) ESPN, saying the sports network is "paying a really big price for its politics (and bad programming). People are dumping it in RECORD numbers. Apologize for untruth!" His tweets came after "SportsCenter" co-host Jemele Hill went on a Twitter rant earlier in the week against the president, calling him a "white supremacist" and "the most ignorant, offensive president of my lifetime." 3. HURRICANE IRMA: President Donald Trump visited Florida earlier this week, after Hurricane Irma caused still uncalculated damages across the state. On Thursday, he tweeted "Just left Florida for D.C. The people and spirit in THAT GREAT STATE is unbelievable. Damage horrific but will be better than ever!" On Monday Barclays analyst Jay Gelb had told investors that Hurricane Irma is expected to have a devastating impact on insurers, but it could have been worse if Miami suffered a direct hit. Nonetheless, Hurricane Harvey and Irma insured losses should top $100B, he argued. In his insurance coverage, Gelb expects re/insurers - including Everest Re (RE), XL Group (XL), RenaissanceRe (RNR), Validus (VR) and Aspen Insurance (AHL) - to take "the brunt of Irma losses." Primary commercial insurers with relatively less exposure likely include Chubb (CB), Travelers (TRV) and Hartford Financial (HIG), while AIG (AIG) could have greater losses among the primary insurers, the analyst contended, adding that Berkshire Hathaway (BRK.A) and Arch Capital (ACGL) likely have relatively modest reinsurance loss exposure, and could therefore expand their presence if pricing substantially improves. Among personal lines insurers, the analyst expects Allstate (ALL) and Progressive (PGR) to have manageable exposure. 4. SINGLE PAYER HEALTHCARE PLAN: On Thursday, President Donald Trump stated in a series of tweets: "Bernie Sanders is pushing hard for a single payer healthcare plan - a curse on the U.S. & its people... I told Republicans to approve healthcare fast or this would happen. But don't worry, I will veto because I love our country & its people." Publicly traded companies in the healthcare insurance space include Aetna (AET), Anthem (ANTM), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG). 5. SELF-DRIVING LEGISLATION: According to a report by Reuters on Wednesday, Navistar (NAV) has asked a U.S Senate panel to add self-driving commercial trucks to an unanimously passed bill that reached the house last week to expedite the use of self-driving cars. While the current bill is only for vehicles under 10,000 pounds, the Senate is considering similar measures for large trucks. "Week in Review" is The Fly's weekly recap of its recurring series of "Trump Effect" exclusive stories.

LSCC

Lattice Semiconductor

$5.46

-0.24 (-4.21%)

DIS

Disney

$98.52

0.62 (0.63%)

MGI

MoneyGram

$15.92

-0.2 (-1.24%)

BABA

Alibaba

$176.70

-0.4 (-0.23%)

RE

Everest Re

$231.66

2.37 (1.03%)

XL

XL Group

$39.37

0.13 (0.33%)

RNR

RenaissanceRe

$135.88

1.55 (1.15%)

VR

Validus

$47.22

-0.01 (-0.02%)

AHL

Aspen Insurance

$41.50

0.45 (1.10%)

CB

Chubb

$143.51

0.72 (0.50%)

TRV

Travelers

$120.70

0.74 (0.62%)

HIG

Hartford Financial

$53.71

0.38 (0.71%)

AIG

AIG

$59.62

-0.19 (-0.32%)

BRK.A

Berkshire Hathaway

$270,200.00

1878 (0.70%)

ACGL

Arch Capital

$96.41

-0.07 (-0.07%)

ALL

Allstate

$90.88

0.38 (0.42%)

PGR

Progressive

$46.02

-0.05 (-0.11%)

AET

Aetna

$162.68

-0.1 (-0.06%)

ANTM

Anthem

$186.59

-0.16 (-0.09%)

CNC

Centene

$95.98

0.06 (0.06%)

CI

Cigna

$186.05

0.82 (0.44%)

HNT

Health Net

HUM

Humana

$249.28

-1.37 (-0.55%)

MOH

Molina Healthcare

$66.62

0.48 (0.73%)

UNH

UnitedHealth

$198.18

0.45 (0.23%)

WCG

WellCare

$177.79

1.61 (0.91%)

NAV

Navistar

$39.14

0.29 (0.75%)

  • 19

    Sep

  • 26

    Sep

  • 27

    Sep

  • 02

    Oct

  • 19

    Oct

  • 24

    Oct

  • 27

    Oct

  • 30

    Oct

  • 08

    Nov

  • 29

    Nov

  • 31

    Jan

LSCC Lattice Semiconductor
$5.46

-0.24 (-4.21%)

11/04/16
JEFF
11/04/16
DOWNGRADE
Target $8.3
JEFF
Hold
Lattice Semiconductor downgraded to Hold from Buy at Jefferies
Jefferies analyst Mark Lipacis downgraded Lattice Semiconductor to Hold citing the takeout by Canyon Bridge Capital Partners. The analyst does not expect a competing bid and raised his price target for the shares to $8.30 from $6.75.
09/14/17
CHLM
09/14/17
NO CHANGE
Target $6
CHLM
Hold
Lattice price target cut after Trump rejects Canyon Bridge deal at Craig-Hallum
Craig-Hallum analyst Richard Shannon lowered his price target for Lattice Semiconductor to $6 from $8.30 after President Trump blocked the Canyon Bridge offer to buy the company for $8.30/share, agreeing with the CFIUS committee's recommendation from two weeks ago. The analyst notes that this is not a surprise given Trump's rhetoric regarding China, even though he thinks the arguments for sensitive technology and military exposure are not well supported. Shannon reiterates a Hold rating on the shares.
09/20/16
SUSQ
09/20/16
INITIATION
Target $7.5
SUSQ
Positive
Lattice Semiconductor initiated with a Positive at Susquehanna
Susquehanna analyst Christopher Rolland initiated Lattice Semiconductor with a Positive and a $7.50 price target saying it is an top acquisition candidate due to potential cost synergies and a strategic portfolio.
DIS Disney
$98.52

0.62 (0.63%)

09/05/17
09/05/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Disney (DIS) upgraded to Outperform from Market Perform at Wells Fargo with analyst Marci Ryvicker saying concerns over potential dilution from the BAMTech stake and the streaming apps are "widely overdone." 2. Patterson-UTI (PTEN) upgraded to Overweight from Neutral at JPMorgan with analyst Sean Meakim saying the 26% selloff since July 19 has created a buying opportunity. 3. lululemon (LULU) upgraded to Positive from Neutral at Susquehanna with analyst Sam Poser citing improved product mix, momentum carrying into the third quarter and inventory flow to stores that is finally supporting consumer engagement. 4. U.S. Steel (X) upgraded to Buy from Neutral at BofA/Merrill with analyst Timna Tanners saying the U.S. premium to Chinese prices has fallen to just about $75/ton, half the leves he considers "normal" and expects HRC can "surge toward $700/ton by year end. 5. Prologis (PLD) upgraded to Buy from Hold at SunTrust with analyst Ki Bin Kim citing valuation and several positive catalysts. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/05/17
WELS
09/05/17
DOWNGRADE
Target $32
WELS
Market Perform
Viacom downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Marci Ryvicker downgraded Viacom (VIAB) to Market Perform and lowered her price target for the shares to $32 from $43. Investors may need to start increasing exposure to media companies with solid streaming strategies given the push into over-the-top, and Viacom does not have one, Ryvicker tells investors in a research note. The analyst does not see much visibility into a turnaround for Viacom's affiliate fee growth. Ryvicker this morning also upgraded Disney (DIS) to Outperform.
09/05/17
WELS
09/05/17
UPGRADE
Target $116
WELS
Outperform
Disney upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Marci Ryvicker upgraded Disney (DIS) to Outperform and raised her price target for the shares to $116 from $109. The owner of ESPN and ABC closed Friday up 31c to $101.50. Concerns over potential dilution from the BAMTech stake and the streaming apps are "widely overdone," Ryvicker tells investors in a research note where she also downgraded Viacom (VIAB). She expects the TV ecosystem will soon undergo on an accelerated push into over-the-top. As such, investors may need to start increasing exposure to media companies with solid streaming strategies, such as CBS (CBS), 21st Century Fox (FOXA), and Disney, and lessen exposure to those that do not, such as Viacom and Scripps Networks (SNI)/Discovery Communications (DISCA), Ryvicker argues. The analyst likes the current entry point for Disney shares.
08/31/17
LOOP
08/31/17
NO CHANGE
Target $106
LOOP
Hold
Impact of 'Force Friday' already reflected in Disney shares, says Loop Capital
Loop Capital analyst David Miller noted that Disney's first "Force Friday" two years ago was a "fantastic success" that pushed the stock up to $119. While the second iteration tomorrow is sure to capture headlines and perhaps even give Disney shares a mild lift, Miller thinks Consumer Products/ Interactive revenue and EBIT growth is already reflected in the stock's price. The analyst, who trimmed his price target on Disney shares to $106 from $107, keeps a Hold rating on the stock.
MGI MoneyGram
$15.92

-0.2 (-1.24%)

07/25/17
DADA
07/25/17
NO CHANGE
DADA
Euronet would benefit if Moneygram deal blocked, says DA Davidson
After media outlets reported that the U.S. government could block the acquisition of Moneygram (MGI) by Alibaba's (BABA) Ant Financial, DA Davidson analyst Peter Heckmann indicates that such a development would help Euronet (EEFT). He notes that Euronet previously made an unsuccessful bid for Moneygram. He believes that if Euronet is able to acquire Moneygram, the deal would be "transformational" and " would provide visibility to attractive revenue and earnings growth into 2020". Conversely, if Ant acquires Moneygram, Euronet and Western Union (WU) could come under increased pressure, the analyst stated. He keeps a Buy rating on Euronet. .
01/30/17
FLTL
01/30/17
DOWNGRADE
FLTL
Hold
MoneyGram downgraded to Hold from Buy at Feltl
Feltl downgraded MoneyGram following its deal to be acquired by Ant Financial for $13.25 per share.
03/14/17
BTIG
03/14/17
NO CHANGE
BTIG
BTIG says Western Union positive reaction to MoneyGram news makes sense
BTIG analyst Mark Palmer said he believes the uptick in Western Union (WU) shares after the announcement of Euronet's (EEFT) offer to buy competitor MoneyGram (MGI) makes some sense as Euronet may be seen as less of a competitive threat than Alibaba's (BABA) Ant Financial, which previously struck a deal to buy MoneyGram, and the bid underscores the attractiveness and potential of the global remittance space. However, speculation that if Ant was unsuccessful in its effort to acquire MoneyGram it could look to acquire VeriFone (PAY) or Green Dot (GDOT) "makes less sense," said Palmer.
03/14/17
RHCO
03/14/17
NO CHANGE
RHCO
Buy
SunTrust says buy Euronet on MoneyGram deal selloff
Euronet's (EEFT) $1.8B offer to acquire MoneyGram (MGI) is "superior in all ways" to Ant Financial's, which is owned by Alibaba (BABA), SunTrust analyst Andrew Jeffrey tells investors in a research note. He expects shares of Euronet to come under pressure this morning "as many investors simply do not like global remittance." Jeffrey recommends using the weakness to buy Euronet, however, as he feels the company has a differentiated franchise and superior management and growth strategy.
BABA Alibaba
$176.70

-0.4 (-0.23%)

09/12/17
MSCO
09/12/17
NO CHANGE
MSCO
Augmented Reality the next 'killer app' to power Apple, says Morgan Stanley
A team of Morgan Stanley analysts including Katy Huberty, Brian Nowak and Grace Chen, among others, state in a new note to investors that they view Augmented Reality, or AR, as a revolutionary trend that can be "the next killer app" to extend the life of the smartphone market and accelerate device upgrades, led by Apple's (AAPL) iPhone. The analysts, who compare the impact of AR to the launch of Apple's App Store nearly a decade ago, add that they "don't expect the Android ecosystem to stand still in response." Huberty and the team raised the firm's "bull case" valuation of Apple, which they see taking the lead in AR, to $253 from $203. While they see Apple as "the clear leader" in AR, Google (GOOG) and Tencent (TCEHY) are also well-positioned and "interesting use cases" in e-commerce could benefit Alibaba (BABA) and Amazon (AMZN), they add.
09/01/17
MKMP
09/01/17
NO CHANGE
Target $76
MKMP
Buy
MKM ups Altaba price target to $76 on higher Alibaba outlook
MKM Partners analyst Rob Sanderson raised his price target for Altaba (AABA) shares to $76 from $62 to reflect a higher outlook for the value of the company's Alibaba (BABA) stake. His new sum-of-the-parts valuation embeds a 12-month price target for Alibaba of $220, current value for other assets and the full 40% tax liability. The pretax value of Altaba's assets is now $95 per share, Sanderson tells investors in a research note. He sees tax efficiencies on the stake, upside in the value of Yahoo Japan (YAHOY) and sale of patents in excess of fair value as potential upside scenarios for Altaba. The analyst keeps a Buy rating on the shares. Altaba closed yesterday down 8c to $64.08.
09/07/17
DBAB
09/07/17
NO CHANGE
Target $199
DBAB
Buy
Alibaba price target lowered to $199 from $208 at Deutsche Bank
Deutsche Bank analyst Alan Hellawell lowered his price target for Alibaba shares to $199 after recalibrating his estimates to reflect higher investment for the rest of fiscal year 2018. The analyst reduced his profit estimates to reflect Alibaba's intention to grow B2C market share and rising video spend. Hellawell maintains his FY18 revenue growth estimate of 48.5% on "continuously improving ad personalization and other data analytics tools increasing merchant ROI." The analyst reiterates a Buy rating on Alibaba.
09/06/17
JPMS
09/06/17
NO CHANGE
Target $200
JPMS
Overweight
Alibaba price target lowered to $200 from $205 at JPMorgan
JPMorgan analyst Alex Yao lowered his price target for Alibaba Group Holding to $200 saying he expects the company's s FY18 non-GAAP EBITDA margin to decline to 43% from 47% in FY17 due to investments across B2C promotions, New Retail and video content. The analyst sees a "mixed outlook" for return on investment, but believes the investments "pave the way for long-term sustainable earnings growth." Yao keeps an Overweight rating on Alibaba.
RE Everest Re
$231.66

2.37 (1.03%)

08/28/17
JPMS
08/28/17
NO CHANGE
JPMS
JPMorgan sees up to $20B of insured losses from Harvey
Harvey could result in $10B-$20B of industry insured losses making it one of the top 10 most costly hurricanes to hit the U.S., JPMorgan analyst Sarah DeWitt tells investors in a research note. The analyst lists Validus (VR), RenaissanceRe (RNR), Everest Re (RE), XL Group (XL), Arch Capital (ACGL), Travelers (TRV), Chubb (CB), Allstate (ALL) and Progressive (PGR) as the property casualty insurers with the most exposure to Texas hurricanes.
09/11/17
LEHM
09/11/17
NO CHANGE
LEHM
Irma and Harvey insured losses expected to top $100B, says Barclays
Barclays analyst Jay Gelb notes initial indications are Hurricane Irma's impact on Florida could result in insured losses of up to $60B. Irma will likely be the largest storm to ever impact the U.S., although not as bad as if Miami suffered a direct hit, Gelb tells investors in a research note on the insurance space titled "Devastating Irma Impact on Insurers, But It Could Have Been Worse." All in, Irma and Harvey insured losses are expected to exceed $100B, Gelb points out. He believes the re/insurance stocks could suffer from near-term uncertainty regarding the extent of losses. Of the names he covers, the analyst expects Everest Re (RE), XL Group (XL), RenaissanceRe (RNR), Validus (VR) and Aspen Insurance (AHL) "to take the brunt of Irma losses." Book value declines of more than 20% could require equity capital raises, Gelb contends. He says Chubb (CB), Travelers (TRV) and Hartford Financial (HIG) have relatively less exposure while AIG (AIG) could have greater losses among the primary insurers.
09/11/17
JPMS
09/11/17
NO CHANGE
JPMS
Irma losses could be lower than expected, says JPMorgan
JPMorgan analyst Sarah DeWitt believes losses from Hurricane Irma could be at the lower end of the $20B-$60B expected range since the storm weakened faster than expected. The analyst estimates the impact to book values for the companies she covers should be a "manageable" 1%-2%. Among the property casualty insurers, the analyst views Validus (VR), Everest Re (RE) and XL Group (XL) as the most oversold. She lists those three along with RenaissanceRe (RNR), Travelers (TRV), Arch Capital (ACGL), Chubb (CB), Allstate (ALL) and Progressive (PGR) as the P&C insurers with the most exposure to U.S. hurricanes.
09/11/17
BUCK
09/11/17
INITIATION
Target $255
BUCK
Neutral
Everest Re initiated with a Neutral at Buckingham
Buckingham analyst Amit Kumar initiated Everest Re with a Neutral and a $255 price target.
XL XL Group
$39.37

0.13 (0.33%)

09/11/17
BUCK
09/11/17
INITIATION
Target $42
BUCK
Neutral
XL Group initiated with a Neutral at Buckingham
Buckingham analyst Amit Kumar initiated XL Group with a Neutral and a $42 price target.
RNR RenaissanceRe
$135.88

1.55 (1.15%)

09/11/17
BUCK
09/11/17
INITIATION
Target $165
BUCK
Buy
RenaissanceRe initiated with a Buy at Buckingham
Buckingham analyst Amit Kumar initiated RenaissanceRe with a Buy and a $165 price target.
VR Validus
$47.22

-0.01 (-0.02%)

09/11/17
BUCK
09/11/17
INITIATION
Target $52
BUCK
Buy
Validus initiated with a Buy at Buckingham
Buckingham analyst Amit Kumar initiated Validus with a Buy and a $52 price target.
AHL Aspen Insurance
$41.50

0.45 (1.10%)

01/09/17
UBSW
01/09/17
DOWNGRADE
Target $55
UBSW
Neutral
Aspen Insurance downgraded to Neutral from Buy at UBS
UBS analyst Brian Meredith downgraded Aspen Insurance to Neutral saying the shares look fairly valued at current levels. He raised his price target for the shares to $55 from $52.
09/11/17
BUCK
09/11/17
INITIATION
Target $44
BUCK
Buy
Aspen Insurance initiated with a Buy at Buckingham
Buckingham analyst Amit Kumar initiated Aspen Insurance with a Buy and a $44 price target.
CB Chubb
$143.51

0.72 (0.50%)

09/11/17
JMPS
09/11/17
UPGRADE
Target $625
JMPS
Outperform
Alleghany upgraded to Outperform from Market Perform at JMP Securities
JMP Securities analyst Matthew Carletti said Hurricane Irma still has the potential to be the largest insured natural catastrophe event in U.S. insurance industry history, though he believes that the property catastrophe market will see a market turn at the coming January 1 renewal. He recommends investors focus near-term on insurers that have lower-than-peer exposure to the event, such as Chubb (CB) and Alleghany (Y), which he upgraded to Outperform from Market Perform with a $625 price target. He also pointed to Amerisafe (AMSF) and ProAssurance (PRA) as insurers with no exposure to Irma losses that have been caught up in the pre-Irma selloff in the space.
09/01/17
MSCO
09/01/17
NO CHANGE
MSCO
Harvey loss uncertainty to remain overhang on P&C stocks, says Morgan Stanley
Morgan Stanley analyst Kai Pan currently estimates $15B-$40B in total insured losses from Harvey, including $5B-$15B in National Flood Insurance Program, or NFIP, claims. P&C stocks the firm covers have declined 2.7% on average since August 23, noted Pan, who thinks the uncertainty of losses will remain a near-term overhang on the group. If the ultimate losses are contained within quarterly earnings, the stocks could rebound, added Pan. Stocks in the P&C insurance space include Allstate (ALL), Travelers (TRV), Progressive (PGR), Chubb (CB), AIG (AIG).
TRV Travelers
$120.70

0.74 (0.62%)

09/11/17
BUCK
09/11/17
INITIATION
Target $136
BUCK
Buy
Travelers initiated with a Buy at Buckingham
Buckingham analyst Amit Kumar initiated Travelers with a Buy and a $136 price target.
HIG Hartford Financial
$53.71

0.38 (0.71%)

06/19/17
DBAB
06/19/17
NO CHANGE
Target $60
DBAB
Buy
Hartford bear case has 'weak premises,' says Deutsche Bank
In a research note titled "Challenging the Bear Case," Deutsche Bank analyst Joshua Shanker argues that the bear case for shares of Hartford Financial has "weak premises." The cases, including a potential material acquisition, the sale of Talcott leading to a material writedown of book value and the company's deferred tax assets having no value, are "insufficient" to hold investors back from buying the shares, Shanker tells investors in a research note. The analyst sees "material" upside potential and keeps a Buy rating on Hartford with a $60 price target.
06/06/17
06/06/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Hartford Financial (HIG) initiated with a Buy at Deutsche Bank. 2. FedEx (FDX) and UPS (UPS) were initiated with a Neutral at Seaport Global. 3. Gardner Denver (GDI) was initiated with an Outperform at William Blair and Baird, an Overweight at Piper Jaffray, a Buy at Stifel, UBS, and Goldman Sachs, as well as a Neutral at Credit Suisse. 4. Solaris Oilfield (SOI) was initiated with an Outperform at Wells Fargo, Oppenheimer, Evercore ISI, and Credit Suisse, an Overweight at Piper Jaffray, as well as a Buy at Goldman Sachs and Wunderlich. 5. LeMaitre (LMAT) initiated with a Hold at Craig-Hallum. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/11/17
BUCK
09/11/17
INITIATION
Target $63
BUCK
Buy
Hartford Financial initiated with a Buy at Buckingham
Buckingham analyst Amit Kumar initiated Hartford Financial with a Buy and a $63 price target.
AIG AIG
$59.62

-0.19 (-0.32%)

09/11/17
BUCK
09/11/17
INITIATION
Target $52
BUCK
Underperform
AIG initiated with an Underperform at Buckingham
Buckingham analyst Amit Kumar initiated AIG with an Underperform and a $52 price target.
08/09/17
08/09/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Starbucks (SBUX) downgraded on more cautious U.S. comp sales outlook at BMO Capital with analyst Andrew Strelzik saying he's "more cautious" on the outlook for the company's U.S. comparable sales, partly due to increased cannibalization of stores, increased competition, "throughput headwinds," and the possibility that "contributions from beverage innovation and food growth may have peaked." 2. Albemarle (ALB) downgraded to Hold from Buy at SunTrust with analyst James Sheehan citing recent share strength. 3. Dean Foods (DF) downgraded to Market Perform from Outperform at Wells Fargo with analyst John Baumgartnerm citing the second quarter miss and "big" guidance reduction. 4. Air Lease (AL) downgraded to Neutral from Buy at BofA/Merrill with analyst Kristine Liwag citing valuation. 5. AIG (AIG) downgraded to Neutral from Overweight at Atlantic Equities. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
BRK.A Berkshire Hathaway
$270,200.00

1878 (0.70%)

07/12/17
LOOP
07/12/17
NO CHANGE
Target $42
LOOP
Buy
Core-Mark unlikely to 'get Amazoned,' says Loop Capital
Loop Capital analyst Andrew Wolf said he sees Core-Mark (CORE) as the least likely company among those he covers to get "Amazoned," or put at risk by Amazon (AMZN) buying a competitor. Its closest competitor McLane, which is owned by Berkshire Hathaway (BRK.B), is highly unlikely to sell to Amazon given that its largest customer is Amazon's rival Wal-Mart (WMT), Wolf tells investors. He keeps a Buy rating on Core-Mark and raised his target on the shares to $42 from $40 citing his increased 2018 EPS forecast.
09/14/17
JPMS
09/14/17
INITIATION
Target $210
JPMS
Overweight
Berkshire Hathaway initiated with an Overweight at JPMorgan
JPMorgan analyst Sarah DeWitt started Berkshire Hathaway (BRK.B) with an Overweight rating and $210 price target. The company "is a collection of best-in-class businesses with unmatched balance sheet strength," DeWitt tells investors in a research note. She thinks Berkshire's largest businesses have structural advantages that will drive faster earnings and book value growth than overall equity markets over time.
09/14/17
09/14/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Berkshire Hathaway (BRK.A, BRK.B) initiated with an Overweight at JPMorgan. 2. BCB Bancorp (BCBP) was initiated with a Buy at DA Davidson and an Outperform at Keefe Bruyette. 3. Koppers Holdings (KOP) reinstated with an Outperform at Barrington. 4. Ferrari (RACE) initiated with a Neutral at Goldman Sachs. 5. Conduent (CNDT) initiated with a Hold at Needham. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/27/17
06/27/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Impinj (PI) was downgraded to Sector Weight from Overweight by Pacific Crest analyst Brad Erickson based on valuation. 2. Mizuho analyst Haendel St. Juste downgraded Store Capital (STOR) to Neutral from Buy citing fair valuation following recent strength driven by Berkshire Hathaway's (BRK.A) investment. 3. Camtek (CAMT) was downgraded to Hold from Buy by Needham analyst Y. Edwin Mok, as he expects to see some deceleration as the PCB business normalizes and he believes large orders for back-end semi inspections are already reflected in the stock after its recent run-up. 4. Nomura Instinet analyst Dan Dolev downgraded Cintas (CTAS) to Neutral from Buy after lowering his FY18 uniform rental organic growth forecasts to 5% from 7%. 5. Atlantic Equities analyst Barry MacCarthy downgraded Hess Corp. (HES) and Schlumberger (SLB), both to Neutral from Overweight, given his view of the limited prospects for an oil price rebound. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
ACGL Arch Capital
$96.41

-0.07 (-0.07%)

09/11/17
MKMP
09/11/17
NO CHANGE
MKMP
Arch Capital, AXIS Capital named as favorable insurance names at MKM Partners
MKM Partners analyst Harry Fong says that Arch Capital (ACGL) "could have the best prospects" in the wake of the recent hurricanes. The analyst says that the company's property catastrophe exposure has dropped significantly, and he reports that the company has estimated its "probable maximum loss in the tri-county area of Florida to be $370M for a 1-in-250 year kind of event," representing "less than 4% of its equity." The analyst adds that the company's on-shore marine business could suffer losses. However, he keeps a $120 price target and a Buy rating on the stock. Fong adds that AXIS has also reduced its property exposure in recent years. However, he adds that Novea which AXIS is looking to purchase could have exposure to Florida. Nonetheless, he thinks that AXIS' risk/reward ratio is positive and he keeps an $80 price target and a Buy rating on the shares. Fong adds that he expects insurers to benefit from significant rate increases going forward that will enable them to erase their hurricane losses in a short time. . He keeps Buy ratings on Allstate (ALL) and Progressive (PGR)
09/11/17
BUCK
09/11/17
INITIATION
Target $106
BUCK
Buy
Arch Capital initiated with a Buy at Buckingham
Buckingham analyst Amit Kumar initiated Arch Capital with a Buy and a $106 price target.
ALL Allstate
$90.88

0.38 (0.42%)

09/11/17
BUCK
09/11/17
INITIATION
Target $74
BUCK
Underperform
Allstate initiated with an Underperform at Buckingham
Buckingham analyst Amit Kumar initiated Allstate with an Underperform and a $74 price target.
PGR Progressive
$46.02

-0.05 (-0.11%)

09/11/17
BUCK
09/11/17
INITIATION
Target $40
BUCK
Underperform
Progressive initiated with an Underperform at Buckingham
Buckingham analyst Amit Kumar initiated AIG with an Underperform and a $40 price target.
AET Aetna
$162.68

-0.1 (-0.06%)

07/13/17
FBCO
07/13/17
NO CHANGE
Target $165
FBCO
Outperform
Aetna price target raised to $165 from $160 at Credit Suisse
Credit Suisse analyst Scott Fidel raised his price target for Aetna to $165 from $160 ahead of Q2 results. He reiterates an Outperform rating on the shares.
06/28/17
06/28/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Altaba (AABA) initiated with an Overweight at JPMorgan. 2. Aetna (AET) and Humana (HUM) were initiated with a Buy at Citi. The firm also added Aetna to its Focus List. 3. CVS Health (CVS) and Walgreens Boots Alliance (WBA) were initiated with a Hold at Needham. 4. Oaktree Capital (OAK) initiated with a Hold at Jefferies. 5. General Motors (GM) resumed with an Overweight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/12/17
ARGS
09/12/17
NO CHANGE
ARGS
Aetna price target raised to $185 from $165 at Argus
Argus analyst David Toung believes that Aetna reported "strong" Q2 results. The analyst remains upbeat on the company's 2H17 outlook and keeps a Buy rating on the shares.
07/14/17
PIPR
07/14/17
NO CHANGE
Target $18
PIPR
Overweight
Piper views updated Aetna policy as disappointing for Natera
Piper Jaffray analyst William Quirk views Aetna's (AET) updated non-invasive prenatal testing medical policy, where it decided to continue covering the test only in high risk, as "disappointing." Upside for Natera (NTRA) in the second half of 2017 now falls on Medicaid and microdeletion reimbursement progress, and less so commercial payers flipping to cover average risk, Quick tells investors in a research note. He keeps an Overweight rating on Natera shares with an $18 price target.
ANTM Anthem
$186.59

-0.16 (-0.09%)

06/28/17
SBSH
06/28/17
NO CHANGE
Target $205
SBSH
Buy
Anthem removed from Focus List at Citi
Citi analyst Ralph Giacobbe removed Anthem (ANTM) from his firm's Focus List but keeps a Buy rating on the shares with a $205 price target. The analyst believes some of the upside catalysts have played out. He also added Aetna (AET) to the Focus List.
07/12/17
FBCO
07/12/17
INITIATION
Target $195
FBCO
Neutral
Anthem initiated with a Neutral at Credit Suisse
Credit Suisse analyst Scott Fidel started Anthem with a Neutral rating and $195 price target. The company has produced slower earnings growth over the past decade relative to Managed Care peers and its returns on capital are also "sub-par relative to comps," the analyst contends. He believes Anthem is "entering a new chapter" following the failed Cigna (CI) acquisition and "uncertain future" of the Affordable Care Act's exchanges and Medicaid expansion.
06/23/17
LEER
06/23/17
NO CHANGE
LEER
Outperform
Draft version of Senate healthcare bill better than expected, says Leerink
Leerink analyst Ana Gupte said she views the draft version of the Senate healthcare bill as better than expected, stating that stabilization of the Exchanges and risk stabilization is a direct positive for health insurers and indirect positive for facility operators. The Senate bill maintains the House bill's plan to repeal all "ObamaCare" industry fees and taxes, which is a positive for Managed Care and Medical Technology players, Gupte adds. She keeps Outperform ratings on Anthem (ANTM), UnitedHealth (UNH), Cigna (CI), Humana (HUM), WellCare (WCG), Molina Healthcare (MOH) and acute care hospital operators HCA Holdings (HCA), Tenet (THC) and LifePoint (LPNT).
06/23/17
JEFF
06/23/17
NO CHANGE
JEFF
Jefferies says healthcare rally 'appropriate' after 'toothless' AHCA rewrite
Jefferies analyst David Windley said the rally yesterday in healthcare stocks was appropriate given the "anemic" rewrite of the AHCA healthcare bill by Senate Republicans. The key changes are removal of "pay-for" taxes, a somewhat longer runway for Exchange cost-sharing reduction subsidies, and delayed Medicaid transition to per capita caps, he tells investors. Windley called Cigna (CI) "probably the safest MCO in this noise", adding that Humana (HUM) would benefit most from the proposed removal of the health insurer fee. Other publicly traded healthcare insurers include Aetna (AET), Anthem (ANTM), Centene (CNC), Health Net (HNT), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
CNC Centene
$95.98

0.06 (0.06%)

09/13/17
LEER
09/13/17
NO CHANGE
Target $90
LEER
Market Perform
Centene price target raised to $90 from $78 at Leerink
Leerink analyst Ana Gupte raised her price target for Centene to $90 from $78 as she is positive on it after the announcement of the Fidelis AMC acquisition. The analyst reiterates a Market Perform rating on the shares.
07/26/17
PIPR
07/26/17
NO CHANGE
Target $105
PIPR
Overweight
Piper says double down on Centene, ups target to $105
Piper Jaffray analyst Sarah James attributes yesterday's post-earnings pullback in shares of Centene to the macro backdrop and the company's spending bump that she believes fuels the bear concern that constant spending for growth pressures margins. The analyst "strongly" disagrees and believe this is when investors should double down on Centene shares. The company will see the greatest multiple expansion in the group and has the highest potential for earnings upside, James tells investors in a research note. She raised her price target for the shares to $105 from $85 and keeps an Overweight rating on the name.
09/13/17
CANT
09/13/17
NO CHANGE
Target $107
CANT
Overweight
Centene price target raised to $107 from $100 at Cantor
Cantor Fitzgerald analyst Steven Halper raised his price target for Centene shares to $107 following the company's acquisition of Fidelis Care. The analyst views the acquisition positively, both from a strategic and financial perspective. He keeps an Overweight rating on Centene.
09/13/17
MSCO
09/13/17
NO CHANGE
Target $94
MSCO
Overweight
Deal for Fidelis 'in Centene's wheelhouse,' says Morgan Stanley
Morgan Stanley analyst Zack Sopcak sees Fidelis Care as a strong fit, both culturally and in terms of business mix, for Centene, calling the acquisition a deal "in Centene's wheelhouse." The analyst, who views the downside to the deal as limited given what he sees as modest synergy targets, keeps an Overweight rating and $94 price target on Centene shares.
CI Cigna
$186.05

0.82 (0.44%)

06/16/17
06/16/17
NO CHANGE

Leerink reiterates view that Cigna could bid for Humana
Leerink analyst Ana Gupte reiterated his views that Cigna (CI) could make a bid Humana (HUM) following Cigna's disclosure that 60% of its Medicare Advantage plans will be in 4-STAR rated plans. The announcement is most positive for Humana (HUM) which is the largest pure play Medicare Advantage name, but also paves the way for Cigna to potentially dievest its legacy HS Medicare Advantage book and bid for Humana.
HNT Health Net

11/09/16
BERN
11/09/16
NO CHANGE
BERN
Health insurers to see multiple catalysts from Trump presidency, says Bernstein
Bernstein analyst Lance Wilkes says that "repealing and replacing Obamacare will be Trump's primary focus." The analyst expects health insurers to benefit from from the repeal of ACA taxes and the elimination of requirements to spend a certain percentage of revenue on medical costs. Wilkes expects Anthem (ANTM) and Blue Cross/Blue Shield providers to benefit from the elimination of public exchanges and broad coverage requirements. Other health insurers include Aetna (AET), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
HUM Humana
$249.28

-1.37 (-0.55%)

08/03/17
PIPR
08/03/17
NO CHANGE
Target $280
PIPR
Overweight
Humana price target raised to $280 from $246 at Piper Jaffray
Piper Jaffray analyst Sarah James raised her price target for Humana to $280 saying the company reported a "strong" beat and raise quarter driven by "strong" Medicare Advantage performance and improved cost control. The analyst sees upside to the current share price and keeps an Overweight rating on Humana.
07/13/17
FBCO
07/13/17
NO CHANGE
Target $250
FBCO
Outperform
Humana price target raised to $250 from $245 at Credit Suisse
Credit Suisse analyst Scott Fidel raised his price target for Humana to $250 from $245 ahead of Q2 results. He reiterates an Outperform rating on the shares.
08/03/17
FBCO
08/03/17
NO CHANGE
Target $260
FBCO
Outperform
Humana price target raised to $260 from $250 at Credit Suisse
Credit Suisse analyst Scott Fidel raised his price target for Humana to $260 from $250 following quarterly results. The analyst reiterates an Outperform rating on the shares.
08/03/17
OPCO
08/03/17
NO CHANGE
Target $255
OPCO
Outperform
Humana price target raised to $255 from $236 at Oppenheimer
Oppenheimer analyst Michael Wiederhorn raised his price target for Humana to $255 from $236 following "strong results" that were driven by outperformance in Medicare Advantage, and after the company raised 2017 EPS guidance. The analyst reiterates an Outperform rating on the shares.
MOH Molina Healthcare
$66.62

0.48 (0.73%)

08/17/17
MSCO
08/17/17
UPGRADE
MSCO
Overweight
Molina Healthcare upgraded to Overweight from Equal Weight at Morgan Stanley
08/17/17
08/17/17
UPGRADE
Target $68

Overweight
Molina Healthcare upgraded to Overweight from Underweight at Morgan Stanley
As previously reported, Morgan Stanley upgraded Molina Healthcare two notches to Overweight from Underweight and raised its price target to $68 from $65. Analyst Zack Sopcak sees a clear path to growth from a clear cost cutting plan and strategy, and favorable risk/reward following the 15% decline in shares since June. The analyst believes interim management's clear restructuring targets are achievable and limit share downside. Sopcak said Molina is on the "cusp" of being the next managed care organization to succeed on a turnaround after bottoming out in Q2.
07/25/17
LEER
07/25/17
NO CHANGE
Target $80
LEER
Outperform
Leerink remains bullish on Molina Healthcare after job cut announcement
Leerink analyst Ana Gupte continues to have "strong conviction" on Molina Healthcare and reiterates an Outperform rating and a $80 price target after the company's announcement from its interim CEO and CFO Joseph White on the elimination of 1,400 jobs, or 10% of its corporate and health plan workforce. The analyst estimates this could expand margins by over 50 bps or offer 50% net margin expansion and get the company by the end of September to the low end of the stated target of 1.5%-2% net margins.
08/17/17
PIPR
08/17/17
NO CHANGE
Target $70
PIPR
Overweight
Molina has sufficient cash without capital raise, says Piper Jaffray
Piper Jaffray analyst Sarah James believes concerns around Molina Healthcare's cash levels, which drove the stock down 5% in the last week, are overdone. After addressing the issue with management, James is "comfortable and confident" that Molina has sufficient cash to meet its needs and has excess reserves without needing an equity raise as feared by bears. The analyst views the shares as undervalued and keeps an Overweight rating on the name with a $70 price target.
UNH UnitedHealth
$198.18

0.45 (0.23%)

08/30/17
ADAM
08/30/17
DOWNGRADE
Target $54
ADAM
Hold
The Advisory Board downgraded to Hold from Buy at Canaccord
Canaccord analyst Richard Close downgraded The Advisory Board (ABCO) to Hold from Buy based on the announced transaction to split the company by selling the Healthcare business to UnitedHealth's (UNH) Optum unit and the Education Business to Vista Equity Partners. Close lowered his price target to $54.29 on Advisory Board shares.
08/29/17
PIPR
08/29/17
NO CHANGE
Target $54.29
PIPR
Neutral
Piper says Advisory Board deal should be marginally accretive to UnitedHealth
Piper Jaffray analyst Sean Wieland said Advisory Board's (ABCO) deal to merge its healthcare business with United Healthcare's (UNH) OptumInsights should be marginally accretive to UnitedHealth and add to his confidence in his FY18 OptumInsights growth estimates. He keeps a Neutral rating on Advisory Board shares and raised his price target on the stock to $54.29 from $51 to reflect the combined estimated amount being paid to shareholders by Optum and Vista Equity, the buyers of Advisory's education business.
08/16/17
PIPR
08/16/17
NO CHANGE
PIPR
Overweight
UnitedHealth made 'solid choice' in new CEO, says Piper Jaffray
Piper Jaffray analyst Sarah James views UnitedHealth's promotion of David Wichmann as a "solid choice and not a surprise." The analyst expects business as usual for the company as it continues to push into technology including artificial intelligence. She has an Overweight rating on the shares.
08/11/17
COWN
08/11/17
NO CHANGE
Target $220
COWN
Outperform
UnitedHealth price target raised to $220 from $175 at Cowen
Cowen analyst Christine Arnold raised her price target on UnitedHealth to $220 from $175. The analyst believes the company can achieve its long-term growth targets in 2018, citing Medicare Advantage enrollment growth, operating efficiencies, commercial market penetration, and OptumRx and OptumInsight earnings gains. Arnold reiterated her Outperform rating on UnitedHealth shares.
WCG WellCare
$177.79

1.61 (0.91%)

08/25/17
CANT
08/25/17
INITIATION
Target $195
CANT
Overweight
WellCare coverage assumed with an Overweight at Cantor
Cantor analyst Steven Halper assumed coverage on WellCare with an Overweight and a $195 price target.
07/13/17
FBCO
07/13/17
NO CHANGE
Target $163
FBCO
Neutral
WellCare price target raised to $163 from $155 at Credit Suisse
Credit Suisse analyst Scott Fidel raised his price target for WellCare to $163 from $155 ahead of Q2 results. He reiterates a Neutral rating on the shares.
08/25/17
08/25/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Walgreens Boots Alliance (WBA) initiated with a Buy and CVS Health (CVS) and Fred's (FRED) initiated with a Hold at Loop Capital. 2. Adobe (ADBE), Intuit (INTU), GoDaddy (GDDY) initiated with a Buy at Jefferies, while Mindbody (MB) was initiated with a Hold. 3. New Oriental Education (EDU), Bright Scholar (BEDU) and TAL Education (TAL) initiated with Overweight ratings at Morgan Stanley. 4. WellCare (WCG) coverage assumed with an Overweight at Cantor. 5. Dollar Tree (DLTR) and Dollar General (DG) reinstated with Buy ratings at BofA/Merrill. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
NAV Navistar
$39.14

0.29 (0.75%)

06/07/17
AGIS
06/07/17
NO CHANGE
Target $36
AGIS
Buy
Aegis says to buy Navistar on any weakness
Aegis analyst Jeffrey Kauffman said Navistar reported a headline Q2 earnings miss but when adjusting for a $60M special charge, operating EBITDA appears to be closer to inline at $125M, and fiscal year guidance was reaffirmed. Kauffman recommends buying Navistar on any weakness and reiterates his Buy rating and a $36 price target.
09/07/17
JEFF
09/07/17
NO CHANGE
Target $47
JEFF
Buy
Navistar price target raised to $47 from $35 at Jefferies
Jefferies analyst Stephen Volkmann raised his price target for Navistar International to $47 saying the company is Q3 "finally reached profitability in all segments." Navistar may have reached the inflection point in profitability with industry volumes expected to improve and the potential positive impact from new products, the analyst contends. He reiterates a Buy rating on the shares.
06/05/17
WELS
06/05/17
NO CHANGE
WELS
May truck orders declined more than expected, says Wells Fargo
Wells Fargo analyst Andrew Casey notes May Class 5-8 truck orders increased 20% year-over-year but declined 11% from April. The month-over-month decline was driven by a 30% Class 8 order decline, partially offset by a 13% Class 5-7 order increase, Casey tells investors in a research note. He notes that May's 16,800 Class 8 order intake was well beneath his channel check-based 21,000-24,000 net order expectation. The analyst views ACT Research's truck data for May as a short-term negative for Cummins (CMI), Eaton (ETN), Paccar (PCAR) and Navistar (NAV).
06/05/17
BARD
06/05/17
UPGRADE
Target $33
BARD
Outperform
Navistar upgraded to Outperform at Baird
As previously reported, Baird analyst David Leiker upgraded Navistar to Outperform from Neutral as the company specific risk/reward looks exceedingly attractive. The analyst said the company's multi-year transformation is near an end and also cites its stabilized market share, improved visibility, and a better balance sheet. Leiker raised his price target to $33 from $32 on Navistar shares.

TODAY'S FREE FLY STORIES

FOXA

21st Century Fox

$26.88

0.12 (0.45%)

, ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

20:04
09/24/17
09/24
20:04
09/24/17
20:04
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

FOXA

21st Century Fox

$26.88

0.12 (0.45%)

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

AVXS

AveXis

$92.11

-4.03 (-4.19%)

RGNX

Regenxbio

$28.25

-1.15 (-3.91%)

BOLD

Audentes Therapeutics

$27.31

-0.1 (-0.36%)

VYGR

Voyager Therapeutics

$17.50

-0.22 (-1.24%)

ORCL

Oracle

$48.16

0.19 (0.40%)

GPRO

GoPro

$10.75

-0.19 (-1.74%)

XLNX

Xilinx

$69.33

0.42 (0.61%)

SNPS

Synopsys

$80.36

0.3 (0.37%)

CDNS

Cadence Design

$38.88

0.45 (1.17%)

SIX

Six Flags

$58.96

1.14 (1.97%)

HMC

Honda

$29.91

0.18 (0.61%)

IRBT

iRobot

$76.14

-3.8 (-4.75%)

AET

Aetna

$153.57

0.18 (0.12%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

CNC

Centene

$92.22

1.48 (1.63%)

CI

Cigna

$182.74

0.61 (0.33%)

HNT

Health Net

HUM

Humana

$239.09

0.45 (0.19%)

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

WCG

WellCare

$167.16

1.1 (0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 28

    Sep

  • 28

    Sep

  • 12

    Oct

  • 24

    Oct

  • 08

    Nov

  • 12

    Jan

NVCR

Novocure

$21.50

-0.1 (-0.46%)

18:27
09/24/17
09/24
18:27
09/24/17
18:27
Hot Stocks
Combination of Novocure Optune with Temozolomide demonstrates five-year survival »

Novocure announced today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Time Warner

$102.40

-0.09 (-0.09%)

, CMCSA

Comcast

$38.10

0.63 (1.68%)

17:10
09/24/17
09/24
17:10
09/24/17
17:10
Hot Stocks
Box Office Battle: 'Kingsman: The Golden Circle' easily wins weekend »

"Kingsman: The…

TWX

Time Warner

$102.40

-0.09 (-0.09%)

CMCSA

Comcast

$38.10

0.63 (1.68%)

CMCSK

Comcast

SNE

Sony

$37.50

0.04 (0.11%)

FOX

21st Century Fox

$26.43

0.1 (0.38%)

FOXA

21st Century Fox

$26.88

0.12 (0.45%)

LGF.A

Lionsgate

$31.49

0.24 (0.77%)

DIS

Disney

$98.60

-0.29 (-0.29%)

VIAB

Viacom

$27.64

0.24 (0.88%)

VIA

Viacom

$38.00

-0.2 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 29

    Sep

  • 22

    Oct

  • 26

    Oct

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

16:41
09/24/17
09/24
16:41
09/24/17
16:41
Periodicals
Amazon affiliate to buy stake in Indian retailer Shoppers Stop, Reuters says »

An affiliate of Amazon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

, GOOG

Alphabet

$928.53

-3.92 (-0.42%)

16:37
09/24/17
09/24
16:37
09/24/17
16:37
Periodicals
Internet giants on the defensive in Washington, Reuters says »

Internet giants,…

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

GOOG

Alphabet

$928.53

-3.92 (-0.42%)

FB

Facebook

$170.54

-0.57 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

  • 29

    Nov

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

, UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

16:25
09/24/17
09/24
16:25
09/24/17
16:25
Periodicals
Opposition to new 'Obamacare' repeal bill grows, Reuters reports »

The new proposal by…

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

CNC

Centene

$92.22

1.48 (1.63%)

WCG

WellCare

$167.16

1.1 (0.66%)

CI

Cigna

$182.74

0.61 (0.33%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

HNT

Health Net

HUM

Humana

$239.09

0.45 (0.19%)

AET

Aetna

$153.57

0.18 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 24

    Oct

  • 08

    Nov

SAP

SAP

$110.27

0.64 (0.58%)

16:11
09/24/17
09/24
16:11
09/24/17
16:11
Hot Stocks
SAP announces acquisition of Gigya »

SAP has announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TATT

TAT Technologies

$10.70

0.05 (0.47%)

, BA

Boeing

$256.45

0.41 (0.16%)

16:03
09/24/17
09/24
16:03
09/24/17
16:03
Hot Stocks
TAT Technologies awarded APU MRO contract for fleet of Boeing, Airbus »

TAT Technologies (TATT),…

TATT

TAT Technologies

$10.70

0.05 (0.47%)

BA

Boeing

$256.45

0.41 (0.16%)

EADSY

Airbus

$23.06

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

GM

General Motors

$39.42

0.32 (0.82%)

11:43
09/23/17
09/23
11:43
09/23/17
11:43
Periodicals
GM to eliminate shift at Tennessee SUV plant on 'moderating' sales, WSJ says »

General Motors has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$54.25

0.19 (0.35%)

11:34
09/23/17
09/23
11:34
09/23/17
11:34
Periodicals
Wells Fargo hires law firm to prepare CEO for Senate appearance, Reuters says »

Wells Fargo has hired law…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 03

    Oct

  • 13

    Oct

  • 22

    Oct

  • 29

    Nov

  • 15

    Jan

EADSY

Airbus

$23.06

-0.01 (-0.04%)

11:27
09/23/17
09/23
11:27
09/23/17
11:27
Periodicals
Airbus in talks to sell all or part of Premium Aerotec, Reuters says »

Airbus is said to be in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGX

Quest Diagnostics

$102.11

0.56 (0.55%)

11:06
09/23/17
09/23
11:06
09/23/17
11:06
Hot Stocks
Quest Diagnostics 'disappointed' with proposed PAMA 2018 Medicare payment rates »

Quest Diagnostics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

IRBT

iRobot

$76.14

-3.8 (-4.75%)

10:58
09/23/17
09/23
10:58
09/23/17
10:58
Periodicals
iRobot suffering after onslaught of SharkNinja cheaper models, Barron's says »

In a follow up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$69.33

0.42 (0.61%)

, SNPS

Synopsys

$80.36

0.3 (0.37%)

10:47
09/23/17
09/23
10:47
09/23/17
10:47
Periodicals
Xilinx, Synopsys are 'rising stars' amid natural evolution of AI, Barron's says »

As everyday items get…

XLNX

Xilinx

$69.33

0.42 (0.61%)

SNPS

Synopsys

$80.36

0.3 (0.37%)

CDNS

Cadence Design

$38.88

0.45 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

UTX

United Technologies

$115.01

0.51 (0.45%)

, COL

Rockwell Collins

$130.48

0.09 (0.07%)

10:42
09/23/17
09/23
10:42
09/23/17
10:42
Periodicals
Major aircraft makers, suppliers face off, Barron's says »

While United Technologies…

UTX

United Technologies

$115.01

0.51 (0.45%)

COL

Rockwell Collins

$130.48

0.09 (0.07%)

BA

Boeing

$256.45

0.41 (0.16%)

EADSY

Airbus

$23.06

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

GPRO

GoPro

$10.75

-0.19 (-1.74%)

10:33
09/23/17
09/23
10:33
09/23/17
10:33
Periodicals
Key events may create 'short squeeze' in GoPro stock, Barron's says »

GoPro, a heavily shorted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMC

Honda

$29.91

0.18 (0.61%)

, RACE

Ferrari

$113.47

-0.1 (-0.09%)

10:17
09/23/17
09/23
10:17
09/23/17
10:17
Periodicals
Honda $200,000 Acura NSX lacks Ferrari 'raw appeal,' Barron's says »

Acura, Honda's (HMC)…

HMC

Honda

$29.91

0.18 (0.61%)

RACE

Ferrari

$113.47

-0.1 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$48.16

0.19 (0.40%)

10:07
09/23/17
09/23
10:07
09/23/17
10:07
Periodicals
Oracle shares could return 20% in a year, Barron's says »

Oracle is a latecomer to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIX

Six Flags

$58.96

1.14 (1.97%)

09:59
09/23/17
09/23
09:59
09/23/17
09:59
Periodicals
Six Flags may have peaked, Barron's says »

Investors have had an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

, AVXS

AveXis

$92.11

-4.03 (-4.19%)

09:51
09/23/17
09/23
09:51
09/23/17
09:51
Periodicals
Gene therapy may be nearing 'major breakthrough,' Baron's says »

Gene therapy is rapidly…

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

AVXS

AveXis

$92.11

-4.03 (-4.19%)

RGNX

Regenxbio

$28.25

-1.15 (-3.91%)

BOLD

Audentes Therapeutics

$27.31

-0.1 (-0.36%)

VYGR

Voyager Therapeutics

$17.50

-0.22 (-1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 12

    Oct

  • 12

    Jan

  • 22

    Sep

AET

Aetna

$153.57

0.18 (0.12%)

, ANTM

Anthem

$182.86

-0.64 (-0.35%)

09:25
09/23/17
09/23
09:25
09/23/17
09:25
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AET

Aetna

$153.57

0.18 (0.12%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

CNC

Centene

$92.22

1.48 (1.63%)

CI

Cigna

$182.74

0.61 (0.33%)

HNT

Health Net

HUM

Humana

$239.09

0.45 (0.19%)

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

WCG

WellCare

$167.16

1.1 (0.66%)

AOBC

American Outdoor Brands

$15.01

-0.15 (-0.99%)

RGR

Sturm, Ruger

$51.00

-1.85 (-3.50%)

WMT

Wal-Mart

$79.53

-0.48 (-0.60%)

PEP

PepsiCo

$111.85

-0.95 (-0.84%)

TGT

Target

$58.99

0.66 (1.13%)

AAPL

Apple

$151.89

-1.5 (-0.98%)

MSFT

Microsoft

$74.41

0.2 (0.27%)

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

TWTR

Twitter

$17.61

0.03 (0.17%)

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

GOOG

Alphabet

$928.53

-3.92 (-0.42%)

FB

Facebook

$170.54

-0.57 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

  • 22

    Oct

  • 24

    Oct

  • 08

    Nov

  • 16

    Nov

  • 21

    Nov

  • 29

    Nov

  • 20

    Feb

AVA

Avista

$51.40

0.1 (0.19%)

18:47
09/22/17
09/22
18:47
09/22/17
18:47
Hot Stocks
Avista receives commission decision in Oregon natural gas rate case »

Avista's natural gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

BMWYY

BMW

$34.00

0.083 (0.24%)

18:40
09/22/17
09/22
18:40
09/22/17
18:40
Periodicals
BMW to build new 8 series in Dingolfing from 2018, Reuters reports »

BMW intends to build its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$33.37

0.67 (2.05%)

18:20
09/22/17
09/22
18:20
09/22/17
18:20
Hot Stocks
Cisco completes acquisition of Springpath »

Cisco announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 22

    Sep

  • 25

    Sep

  • 26

    Sep

  • 28

    Sep

  • 29

    Sep

  • 05

    Oct

  • 06

    Oct

  • 18

    Oct

  • 19

    Oct

  • 22

    Oct

  • 15

    Nov

  • 07

    Dec

  • 11

    Dec

BMY

Bristol-Myers

$63.36

0.03 (0.05%)

18:12
09/22/17
09/22
18:12
09/22/17
18:12
Hot Stocks
Bristol-Myers announces FDA approval of Opdivo »

Bristol-Myers announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 18

    Oct

  • 26

    Oct

  • 08

    Nov

  • 09

    Nov

  • 05

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.